Agios Pharmaceuticals, Inc. (AGIO)

28.54 -0.12 (-0.42%) USD  |  NASDAQ  |  Jan 23, 16:00
28.54 0.00 (0.00%) After-Hours: 20:00
More

Agios Pharmaceuticals Research and Development Expense (TTM): 329.01M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for AGIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 10.13B
CorMedix, Inc. 12.46M
Dynavax Technologies Corp. 73.78M
Fulcrum Therapeutics, Inc. 51.08M
Moderna, Inc. 3.271B